Friday, September 30, 2011 – 9:46 AM

Beacon Angels is currently participating pro rata to its prior investments in a $1.5M follow-on, Series C investment round in portfolio company, Boston Heart Diagnostics.

Monday, September 12, 2011 – 2:52 PM

In July, Beacon participated pro rata in a $1 million extension of the Series A-1 round in Copiun, Inc., of Copiun, a portfolio company that offers enterprise data storage solutions.

Wednesday, August 31, 2011 – 2:14 PM

Angels really did fill the “financing gap” here and elsewhere, and continue to do so. See http://www.theatlantic.com/business/archive/2011/08/who-saved-silicon-valley-angels-of-course/243983/ for details.

Friday, June 17, 2011 – 12:01 PM

Beacon Angels is currently conducting due diligence in InfoBionic, a medical devices company that is creating a single platform and solution for comprehensive remote physiological monitoring with a focus on arrhythmia detection. InfoBionic recently won the Piranha Pond competition hosted by 128 Innovation Capital Group.

Friday, June 17, 2011 – 12:01 PM

Beacon Angels is currently conducting due diligence in Cytosolve, an in-silico drug development company offering a new paradigm for drug development.

Friday, June 17, 2011 – 12:01 PM

Beacon Angels is currently conducting due diligence in Abroad 101, a web site that provides user-generated reviews of study abroad programs for students and universities.

Tuesday, June 7, 2011 – 4:14 PM

Beacon Angels is currently conducting due diligence in VoiceFriend, which provides commincations management services to elder communities.

Wednesday, May 4, 2011 – 3:21 PM

Beacon Angels congratulates Jean Hammond and other Boston area angels on the successful IPO of Zipcar, Inc. (ZIP on NASDAQ: Out at 18, peaked at 29; holding at 24. Could become the Netflix of car rentals.

Thursday, April 7, 2011 – 2:49 PM

Observations from this week’s national ACA Summit in Cambridge, Mass.:

• Kendall Sq. is looking terrific as a place to work (in biotech) or go to school (at MIT);
• Whilst the same ACA member-managers show up every year, it’s the individual investors that add the savor to the ACA soup;
• Locally based angels go up to the microphone the most;
• Valley-based angels do the most bragging, regardless of where the conference is held;
• Midwestern angels express a great deal of pride about their state’s angel scene–when the conference is held in the Midwest;
• Boston/New England angels are pretty good about neither bragging nor complaining, but we certainly did talk up SmartCells;
• Canadian angels keep a relatively low profile, unless they’re from Vancouver;
• The ACA has been around long enough for its members to report on their own favorite exits;
• Comprehensive, reliable statistics about angels’ successes or lack thereof, are still unavailable;
• SmartCells’ exit raised the bar for pre-clinical drug exits from $20m to $100m (but not to $500m);
• If the SmartCells milestones prove to be golden, its Boston angels’ multiples will surpass those of the Valley’s angels without the need for a messy IPO;
• Some messy, angel backed IPOs certainly would be nice to have in Boston/New England.

Wednesday, March 30, 2011 – 4:34 PM

Some of us will be attending the annual Summit of the Angel Capital Association, which will be held in Boston next week, April 4-6, at the Boston Marriot Cambridge. Here is the complete agenda.

Thursday, March 10, 2011 – 2:16 PM

Beacon Members Bill Swiggart, Norm Meisner and Richard Noyes conducted the panel discussion: “Beacon Angels – How We Do What We Do – Stories from the Trenches” before the Rt. 128 Innovation Capital Group at the IBM Innovation Center. http://ow.ly/4bUj9